US EditionPublished • loading... • Updated
Catheter Precision Divests Non-Core Assets As It Shifts Focus - Catheter Precision (AMEX:VTAK)
Summary by Benzinga
2 Articles
2 Articles
Catheter Precision Announces Strategic Sale of Non-Core Assets to Strengthen Balance Sheet and Accelerate Electrophysiology Growth
Upfront Cash, Equity Participation and Tiered Royalty Structure Providing Long-Term Revenue Upside FORT MILL, S.C., Feb. 19, 2026 (GLOBE NEWSWIRE) -- Catheter Precision, Inc....
·Manila, Philippines (the)
Read Full Article
Catheter Precision Divests Non-Core Assets As It Shifts Focus - Catheter Precision (AMEX:VTAK)
Catheter Precision (NYSE:VTAK) shares are down on Thursday as the company announced a strategic divestiture of its non-core assets. VTAK Sells Atherectomy Catheter Tech to Focus on Electrophysiology Catheter Precision on Thursday agreed to sell its atherectomy catheter technologies, including associated FDA approvals and patents, to a strategic acquirer. This decision aims to enhance capital efficiency and sharpen the company’s focus on its high…
·New York, United States
Read Full ArticleCoverage Details
Total News Sources2
Leaning Left0Leaning Right1Center1Last UpdatedBias Distribution50% Center, 50% Right
Bias Distribution
- 50% of the sources are Center, 50% of the sources lean Right
50% Right
C 50%
R 50%
Factuality
To view factuality data please Upgrade to Premium
